Delivery Order SPE2DB24D9313-SPE2DB25FFFHR

Award Date 1/30/25
Potential Completion Date 2/21/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price Delivery Order valued at $10,070.20. The contract was awarded by the Defense Logistics Agency (DLA) to provide the KYLEENA 19.5 MG SYSTEMS product. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,203.86 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,407.72, is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical supplies...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,002.81 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,859.07 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award, with ID SPE2DB22D9225|SPE2DB24FR8FD, is a $3,611.58 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 4565261929 - KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant single-award...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the provision of a pharmaceutical product called KYLEENA 19.5MG SYS 1S. The contract, awarded by the Defense Logistics Agency (DLA) under its Medical Supply Chain program, is a delivery order with a firm fixed price of $1,203.84 and a completion date of May 2, 2024. The contract does not have a set-aside designation. Through this award, DMS Pharmaceutical Group will supply the specified...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,209.88 firm fixed-price delivery order is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS, with a period of performance through November 1, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This federal contract award is a delivery order valued at $2,919.35 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the supply of a pharmaceutical product called "KYLEENA 19.5 MG SYSTEMS" and has a performance period through October 4, 2024. DMS Pharmaceutical Group holds a large indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,611.58, is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. The contract has an ultimate completion date of May 30, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a...
  • SPE2DB24D9313
    Indefinite Delivery Contract
  • SPE2DB24D9313-SPE2DB25FFFHR
    Delivery Order

This federal contract award, with ID SPE2DB24D9313|SPE2DB25FFFHR, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,239.38, is for the provision of 4,567,138,193 units of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. The contract does not have a set-aside designation.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of pharmaceutical products and medical supplies to the Department of Defense (DoD). The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Generated 5/4/25, 1:03 AM